Predictive Oncology Stock to Reverse Split on Tuesday, September 30th (NASDAQ:POAI)

Predictive Oncology Inc. (NASDAQ:POAI) shares are scheduled to reverse split on Tuesday, September 30th. The 1-15 reverse split was announced on Thursday, September 25th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, September 29th.

Predictive Oncology Stock Performance

Predictive Oncology stock opened at $0.95 on Friday. The company’s fifty day moving average price is $0.89 and its 200 day moving average price is $0.98. Predictive Oncology has a 1 year low of $0.55 and a 1 year high of $3.06. The stock has a market capitalization of $10.35 million, a P/E ratio of -0.31 and a beta of 1.37.

Predictive Oncology (NASDAQ:POAI) last released its quarterly earnings results on Wednesday, August 13th. The medical instruments supplier reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.13). Predictive Oncology had a negative net margin of 587.31% and a negative return on equity of 722.01%. The company had revenue of $0.00 million during the quarter, compared to analyst estimates of $1.50 million. Sell-side analysts predict that Predictive Oncology will post -2.08 EPS for the current year.

Predictive Oncology Company Profile

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.